Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 3
1953 1
1961 1
1975 1
1977 3
1978 4
1979 1
1980 5
1982 2
1983 1
1985 1
1986 2
1989 2
1990 1
1993 1
1995 1
1996 2
1997 2
2004 2
2006 3
2008 3
2009 2
2010 5
2011 6
2012 2
2013 2
2014 3
2015 2
2016 3
2017 2
2018 1
2019 6
2020 5
2021 10
2022 10
2023 13
2024 5
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Ytterberg SR, et al. N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927. N Engl J Med. 2022. PMID: 35081280 Clinical Trial.
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
McInnes IB, Mease PJ, Kirkham B, Kavanaugh A, Ritchlin CT, Rahman P, van der Heijde D, Landewé R, Conaghan PG, Gottlieb AB, Richards H, Pricop L, Ligozio G, Patekar M, Mpofu S; FUTURE 2 Study Group. McInnes IB, et al. Lancet. 2015 Sep 19;386(9999):1137-46. doi: 10.1016/S0140-6736(15)61134-5. Epub 2015 Jun 28. Lancet. 2015. PMID: 26135703 Free article. Clinical Trial.
Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl.
Thakrar AP, Christine PJ, Siaw-Asamoah A, Spadaro A, Faude S, Snider CK, Delgado MK, Lowenstein M, Kampman K, Perrone J, Nelson LS, Kilaru AS. Thakrar AP, et al. Among authors: lowenstein m. JAMA Netw Open. 2024 Sep 3;7(9):e2435895. doi: 10.1001/jamanetworkopen.2024.35895. JAMA Netw Open. 2024. PMID: 39331392 Free PMC article.
Choosing Our Words Wisely.
Lowenstein M. Lowenstein M. JAMA Intern Med. 2016 Sep 1;176(9):1249-50. doi: 10.1001/jamainternmed.2016.3653. JAMA Intern Med. 2016. PMID: 27455463 No abstract available.
Mapping Buprenorphine Access at Philadelphia Pharmacies.
Aronowitz SV, French R, Schachter A, Seeburger E, O'Donnell N, Perrone J, Lowenstein M. Aronowitz SV, et al. Among authors: lowenstein m. J Addict Med. 2024 May-Jun 01;18(3):269-273. doi: 10.1097/ADM.0000000000001284. Epub 2024 Feb 12. J Addict Med. 2024. PMID: 38345212 Free PMC article.
Wound Characteristics Among Patients Exposed to Xylazine.
Lutz L, McFadden R, Xu L, Bhatia R, Davis MH, Rohacs N, Wei J, Perrone J, Lowenstein M, Thakrar AP. Lutz L, et al. Among authors: lowenstein m. JAMA Dermatol. 2025 Jan 1;161(1):75-80. doi: 10.1001/jamadermatol.2024.4253. JAMA Dermatol. 2025. PMID: 39535749
Severe Fentanyl Withdrawal Associated With Medetomidine Adulteration: A Multicenter Study From Philadelphia, PA.
London KS, Huo S, Murphy L, Warrick-Stone T, Goodstein D, Montesi M, Carter M, Butt S, Alexander K, Satz W, Tasillo A, Xu L, Arora M, Casey E, McKeever R, Lowenstein M, Durney P, Hart B, Perrone J. London KS, et al. Among authors: lowenstein m. J Addict Med. 2025 Aug 1. doi: 10.1097/ADM.0000000000001560. Online ahead of print. J Addict Med. 2025. PMID: 40747932
118 results